Variant report

Variant	nsv892072
Chromosome Location	chr9:2619915-2623253
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:452)
CpG islands
(count:307)
Chromatin interactive
region (count:4)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:452 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr9:2621410-2621682	H1-hESC	embryonic stem cell:	n/a	n/a
2	BATF	chr9:2621293-2621482	GM12878	blood:	n/a	n/a
3	BATF	chr9:2621265-2621528	GM12878	blood:	n/a	n/a
4	BHLHE40	chr9:2621256-2621931	GM12878	blood:	n/a	chr9:2621658-2621674 chr9:2621798-2621814 chr9:2621583-2621599 chr9:2621799-2621815
5	BHLHE40	chr9:2623210-2623849	GM12878	blood:	n/a	chr9:2623484-2623493 chr9:2623485-2623494 chr9:2623485-2623494
6	BHLHE40	chr9:2622428-2622971	GM12878	blood:	n/a	chr9:2622781-2622797 chr9:2622746-2622762
7	BHLHE40	chr9:2621446-2621718	K562	blood:	n/a	chr9:2621658-2621674 chr9:2621583-2621599
8	BHLHE40	chr9:2621241-2621747	HepG2	liver:	n/a	chr9:2621658-2621674 chr9:2621583-2621599
9	CCNT2	chr9:2621423-2621804	K562	blood:	n/a	n/a
10	CEBPB	chr9:2621194-2621559	MCF-7	breast:	n/a	n/a
11	CEBPB	chr9:2621212-2621491	K562	blood:	n/a	n/a
12	CEBPB	chr9:2621158-2621559	H1-hESC	embryonic stem cell:	n/a	n/a
13	CEBPB	chr9:2621167-2621499	A549	lung:	n/a	n/a
14	CEBPB	chr9:2621171-2621587	HepG2	liver:	n/a	n/a
15	CEBPB	chr9:2621303-2621449	HepG2	liver:	n/a	n/a
16	CEBPB	chr9:2621155-2621549	IMR90	lung:	n/a	n/a
17	CEBPB	chr9:2621175-2621530	HepG2	liver:	n/a	n/a
18	CEBPB	chr9:2621124-2621632	A549	lung:	n/a	n/a
19	CHD1	chr9:2622947-2623141	H1-hESC	embryonic stem cell:	n/a	n/a
20	CHD1	chr9:2621190-2621402	H1-hESC	embryonic stem cell:	n/a	n/a
21	CHD1	chr9:2620886-2622127	IMR90	lung:	n/a	n/a
22	CHD2	chr9:2621351-2621538	GM12878	blood:	n/a	n/a
23	CHD2	chr9:2621237-2621569	H1-hESC	embryonic stem cell:	n/a	n/a
24	CREB1	chr9:2621228-2621757	A549	lung:	n/a	n/a
25	CREB1	chr9:2621101-2621956	HepG2	liver:	n/a	n/a
26	CREB1	chr9:2622068-2622398	A549	lung:	n/a	n/a
27	CTBP2	chr9:2621174-2621616	H1-hESC	embryonic stem cell:	n/a	n/a
28	CTBP2	chr9:2622199-2623772	H1-hESC	embryonic stem cell:	n/a	n/a
29	CTCF	chr9:2622320-2622470	HA-sp	spinal cord:	n/a	n/a
30	CTCF	chr9:2621260-2621410	BJ	skin:	n/a	n/a
31	CTCF	chr9:2621300-2621450	SAEC	small airway:	n/a	n/a
32	CTCF	chr9:2621326-2621472	Pancreas_OC	pancreas:	n/a	n/a
33	CTCF	chr9:2622323-2622497	MCF-7	breast:	n/a	n/a
34	CTCF	chr9:2622342-2622429	MCF-7	breast:	n/a	n/a
35	CTCF	chr9:2622420-2622570	GM12864	blood:	n/a	n/a
36	CTCF	chr9:2621340-2621490	GM12871	blood:	n/a	n/a
37	CTCF	chr9:2622320-2622470	HPAF	blood vessel:	n/a	n/a
38	CTCF	chr9:2622197-2622498	LNCaP	prostate:	n/a	n/a
39	CTCF	chr9:2621340-2621490	HMF	breast:	n/a	n/a
40	CTCF	chr9:2622742-2622829	GM12891	blood:	n/a	chr9:2622750-2622763
41	CTCF	chr9:2622300-2622450	SAEC	small airway:	n/a	n/a
42	CTCF	chr9:2622360-2622510	HBMEC	blood vessel:	n/a	n/a
43	CTCF	chr9:2622727-2622841	LNCaP	prostate:	n/a	chr9:2622750-2622763
44	CTCF	chr9:2622534-2622543	GM19238	blood:	n/a	n/a
45	CTCF	chr9:2622340-2622490	AoAF	blood vessel:	n/a	n/a
46	CTCF	chr9:2621360-2621510	AoAF	blood vessel:	n/a	n/a
47	CTCF	chr9:2622300-2622450	GM06990	blood:	n/a	n/a
48	CTCF	chr9:2621360-2621510	HMEC	breast:	n/a	n/a
49	CTCF	chr9:2622503-2622504	LNCaP	prostate:	n/a	n/a
50	CTCF	chr9:2621240-2621390	HAc	cerebellar:	n/a	n/a

(count:307 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:2621094-2621144	SK-N-MC	brain:	n/a
2	chr9:2621094-2621144	Caco-2	colon:	n/a
3	chr9:2621094-2621144	SK-N-MC	brain:	n/a
4	chr9:2621094-2621144	Caco-2	colon:	n/a
5	chr9:2623146-2623196	U87	brain:	n/a
6	chr9:2621918-2621968	GM12891	blood:	n/a
7	chr9:2621379-2621429	AG04450	lung:	fetal
8	chr9:2621918-2621968	LNCaP	prostate:	n/a
9	chr9:2621918-2621968	U87	brain:	n/a
10	chr9:2621379-2621429	K562	blood:	n/a
11	chr9:2621094-2621144	ovcar-3	ovarian:	n/a
12	chr9:2621918-2621968	HepG2	liver:	n/a
13	chr9:2622584-2622634	ECC-1	luminal epithelium:	n/a
14	chr9:2623146-2623196	Jurkat	blood:	n/a
15	chr9:2623146-2623196	MCF-7	breast:	n/a
16	chr9:2621094-2621144	HNPCEpiC	eye:	n/a
17	chr9:2621918-2621968	SK-N-MC	brain:	n/a
18	chr9:2621379-2621429	H1-hESC	embryonic stem cell:	embryo
19	chr9:2621094-2621144	HMEC	breast:	n/a
20	chr9:2623146-2623196	HNPCEpiC	eye:	n/a
21	chr9:2623146-2623196	A549	lung:	n/a
22	chr9:2621379-2621429	HepG2	liver:	n/a
23	chr9:2622584-2622634	HCPEpiC	choroid plexus:	n/a
24	chr9:2622584-2622634	GM12892	blood:	n/a
25	chr9:2621379-2621429	RPTEC	kidney:	n/a
26	chr9:2621379-2621429	HCPEpiC	choroid plexus:	n/a
27	chr9:2622584-2622634	IMR90	lung:	fetal
28	chr9:2621918-2621968	HCPEpiC	choroid plexus:	n/a
29	chr9:2621379-2621429	HRE	kidney:	n/a
30	chr9:2621379-2621429	Jurkat	blood:	n/a
31	chr9:2621094-2621144	BJ	skin:	n/a
32	chr9:2621379-2621429	HRPEpiC	eye:	n/a
33	chr9:2621918-2621968	RPTEC	kidney:	n/a
34	chr9:2621379-2621429	GM12891	blood:	n/a
35	chr9:2622584-2622634	NT2-D1	testis:	n/a
36	chr9:2621094-2621144	HEK293	kidney:	embryo
37	chr9:2621379-2621429	HAEpiC	amniotic membrane:	n/a
38	chr9:2621094-2621144	HRPEpiC	eye:	n/a
39	chr9:2623146-2623196	Caco-2	colon:	n/a
40	chr9:2621379-2621429	BJ	skin:	n/a
41	chr9:2623146-2623196	BJ	skin:	n/a
42	chr9:2621094-2621144	GM19239	blood:	n/a
43	chr9:2621094-2621144	HEEpiC	esophagus:	n/a
44	chr9:2621094-2621144	HL-60	blood:	n/a
45	chr9:2622584-2622634	U87	brain:	n/a
46	chr9:2622584-2622634	LNCaP	prostate:	n/a
47	chr9:2621094-2621144	HIPEpiC	eye:	n/a
48	chr9:2621918-2621968	NB4	blood:	n/a
49	chr9:2622584-2622634	HMEC	breast:	n/a
50	chr9:2623146-2623196	HCF	heart:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:2622798..2625667-chr9:2640741..2642429,2	K562	blood:
2	chr9:2618162..2620045-chr9:2621820..2624612,2	K562	blood:
3	chr9:2621566..2623636-chr9:2638581..2641950,3	MCF-7	breast:
4	chr9:2620987..2624573-chr9:2639977..2643677,3	MCF-7	breast:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KIAA0020-1	chr9:2619998-2621792	NONHSAT130002
2	lnc-KIAA0020-1	chr9:2621229-2621413	ENSG00000236404.4
3	lnc-KIAA0020-1	chr9:2622100-2622373	ENSG00000236404
4	lnc-KIAA0020-1	chr9:2622100-2622373	NR_015375
5	lnc-KIAA0020-1	chr9:2621229-2621413	ENSG00000236404

No data

Variant related genes	Relation type
ENSG00000236404	TF binding region
VLDLR	TF binding region
ENSG00000236404	CpG island
VLDLR	CpG island
ENSG00000147852	chromatin interactions
ENSG00000236404	chromatin interactions
SPRED1	miRNA target sites

Extended variants
information (count: 154 )
Associated
traits (count: 107 )

Variant overlapped rSNPs/rCNVs (count:154 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs12057080	chr9:2619915-2619916	Weak transcription Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs35792530	chr9:2619930-2619931	Weak transcription Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs571808251	chr9:2619973-2619974	Weak transcription Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs370955973	chr9:2619994-2619995	Weak transcription Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs554376459	chr9:2620005-2620006	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
6	rs377341648	chr9:2620049-2620050	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
7	rs76642891	chr9:2620107-2620108	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
8	rs536919438	chr9:2620114-2620115	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
9	rs139070066	chr9:2620133-2620134	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
10	rs142267062	chr9:2620134-2620135	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
11	rs188087169	chr9:2620159-2620160	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
12	rs558221942	chr9:2620160-2620161	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
13	rs77207549	chr9:2620167-2620168	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
14	rs146268085	chr9:2620172-2620173	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
15	rs561101582	chr9:2620240-2620241	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
16	rs116386996	chr9:2620265-2620266	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
17	rs35775773	chr9:2620274-2620275	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
18	rs138781719	chr9:2620307-2620308	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
19	rs374662971	chr9:2620318-2620319	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
20	rs531725602	chr9:2620333-2620334	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
21	rs35840674	chr9:2620346-2620347	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
22	rs34188145	chr9:2620365-2620366	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
23	rs555347663	chr9:2620389-2620390	Bivalent/Poised TSS Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
24	rs527761682	chr9:2620423-2620424	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
25	rs547592969	chr9:2620428-2620429	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
26	rs143480159	chr9:2620478-2620479	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
27	rs536450868	chr9:2620482-2620483	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
28	rs34518363	chr9:2620512-2620513	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
29	rs570055126	chr9:2620534-2620535	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
30	rs35837671	chr9:2620555-2620556	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs35845312	chr9:2620592-2620593	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
32	rs145936604	chr9:2620597-2620598	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
33	rs541078658	chr9:2620600-2620601	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
34	rs571900943	chr9:2620625-2620626	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
35	rs191347489	chr9:2620644-2620645	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
36	rs35652589	chr9:2620661-2620662	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
37	rs574569629	chr9:2620892-2620893	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
38	rs543290431	chr9:2620962-2620963	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
39	rs563556701	chr9:2620975-2620976	Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
40	rs532480122	chr9:2621021-2621022	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
41	rs1454626	chr9:2621030-2621031	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	mRNA abundance
42	rs565246426	chr9:2621035-2621036	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
43	rs182980844	chr9:2621058-2621059	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
44	rs547823761	chr9:2621079-2621080	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
45	rs545254724	chr9:2621092-2621093	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
46	rs7043199	chr9:2621145-2621146	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs187639366	chr9:2621156-2621157	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
48	rs543125758	chr9:2621174-2621175	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
49	rs563429300	chr9:2621175-2621176	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
50	rs35209383	chr9:2621177-2621178	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:107)

Disease	PMID	Source
Gastric cancer	16715143	CNVD
Glioblastoma multiforme	22286061	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Disorders of sex development	21048976	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Myelofibrosis	22110671	CNVD
Developmental delay	21373258	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Hepatocellular carcinoma	18803288	CNVD
Schizophrenia	23813976	CNVD
Ovarian cancer	22355333	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Schizophrenia	20967226	CNVD
Ovarian cancer	21781307	CNVD
T-cell lymphomas	22341440	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:460 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:2614200-2621000	Weak transcription	Pancreas	Pancrea
2	chr9:2614200-2621200	Weak transcription	Lung	lung
3	chr9:2614400-2620600	Weak transcription	Right Atrium	heart
4	chr9:2614400-2621000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
5	chr9:2615800-2620000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
6	chr9:2616000-2620000	Weak transcription	H1 Cell Line	embryonic stem cell
7	chr9:2616000-2620200	Weak transcription	Brain Angular Gyrus	brain
8	chr9:2616000-2620200	Weak transcription	Brain Hippocampus Middle	brain
9	chr9:2616000-2620200	Weak transcription	Brain Inferior Temporal Lobe	brain
10	chr9:2616000-2620200	Weak transcription	Brain Substantia Nigra	brain
11	chr9:2616400-2620600	Weak transcription	Fetal Stomach	stomach
12	chr9:2616600-2620200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
13	chr9:2616800-2620800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
14	chr9:2616800-2621000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr9:2619200-2620600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
16	chr9:2619400-2620600	Weak transcription	Fetal Heart	heart
17	chr9:2619600-2620200	Active TSS	H9 Cell Line	embryonic stem cell
18	chr9:2619800-2624000	Active TSS	Ovary	ovary
19	chr9:2620000-2620200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
20	chr9:2620000-2620200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
21	chr9:2620000-2620200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
22	chr9:2620000-2620200	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
23	chr9:2620000-2620400	Flanking Active TSS	H1 Cell Line	embryonic stem cell
24	chr9:2620000-2620400	Bivalent/Poised TSS	Fetal Brain Female	brain
25	chr9:2620000-2620400	Enhancers	Pancreatic Islets	Pancreatic Islet
26	chr9:2620000-2620400	Enhancers	Dnd41	blood
27	chr9:2620000-2620600	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
28	chr9:2620000-2620600	Enhancers	Fetal Brain Male	brain
29	chr9:2620000-2620800	Enhancers	Brain Cingulate Gyrus	brain
30	chr9:2620000-2624000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
31	chr9:2620000-2624200	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
32	chr9:2620200-2620400	Flanking Active TSS	H9 Cell Line	embryonic stem cell
33	chr9:2620200-2620400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
34	chr9:2620200-2620400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
35	chr9:2620200-2620400	Enhancers	Brain Angular Gyrus	brain
36	chr9:2620200-2620400	Enhancers	Brain Inferior Temporal Lobe	brain
37	chr9:2620200-2620600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
38	chr9:2620200-2620600	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
39	chr9:2620200-2620600	Enhancers	Brain Germinal Matrix	brain
40	chr9:2620200-2620600	Enhancers	Brain Hippocampus Middle	brain
41	chr9:2620200-2620600	Active TSS	NHEK	skin
42	chr9:2620200-2620800	Enhancers	Breast Myoepithelial Primary Cells	Breast
43	chr9:2620200-2620800	Enhancers	Adipose Nuclei	Adipose
44	chr9:2620200-2620800	Enhancers	Skeletal Muscle Female	skeletal muscle
45	chr9:2620200-2621000	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
46	chr9:2620200-2621000	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
47	chr9:2620200-2621000	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
48	chr9:2620200-2621000	Enhancers	Brain Substantia Nigra	brain
49	chr9:2620200-2621000	Active TSS	Stomach Smooth Muscle	stomach
50	chr9:2620200-2621400	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links